BrightPath Biotherapeutics Co., Ltd.
4594ブライトパス・バイオ株式会社
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-14For the first half of the fiscal year to 2026-03: Revenue ¥0 billion (-41.1% YoY), Ordinary income ¥-0.5 billion, Net income ¥-0.5 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥0m | -41.1% |
| Ordinary profit | −¥461m | — |
| Net profit to owners | −¥463m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4594/earnings-releases.
Financials
Japan GAAP · non-consolidated · fiscal year to 2026-03-31- Revenue
- ¥0m
- Net income
- −¥1.3bn
- ROE
- —
- Equity ratio
- 90.1%
- Dividend / share
- —
- Employees
- 23
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥0m | −¥1,305m | ¥2,605m | ¥2,368m | — | ¥-11.7 | −¥1,366m |
| 2025-03-31 | ¥1m | −¥1,151m | ¥1,121m | ¥925m | — | ¥-14.12 | −¥1,250m |
| 2024-03-31 | ¥0m | −¥1,168m | ¥1,230m | ¥979m | — | ¥-18.21 | −¥1,157m |
| 2023-03-31 | ¥5m | −¥1,486m | ¥1,701m | ¥1,568m | — | ¥-24.9 | −¥1,204m |
| 2022-03-31 | ¥15m | −¥1,484m | ¥2,771m | ¥2,531m | — | ¥-28.55 | −¥1,512m |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -15,399.2024 | 0 |
| Equity ratio, % | 90.1 | 98.4 |
| Revenue growth | -0.9259 | 0.1 |
| Net income growth | -0.1336 | 26.2 |
| Operating cash flow / assets | -0.5243 | 0.6 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Via /v1/companies/4594/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themOwnership changes
All companies →- 2026-10-07
PhillipCapital Japan Ltd. disclosed a 19.90% stake in BrightPath Biotherapeutics Co., Ltd. (4594), crossing the 5% reporting threshold.
- 2026-10-07
Holdings of PhillipCapital Japan Ltd. in BrightPath Biotherapeutics Co., Ltd. (4594) moved above 10% (new -> 19.90%).
- 2026-02-19
Phillip Securities Japan,Ltd. cut holdings in BrightPath Biotherapeutics Co., Ltd. (4594) to 4.88% from 6.29%, below the 5% threshold.
- 2026-01-29
Phillip Securities Japan,Ltd. reduced holdings in BrightPath Biotherapeutics Co., Ltd. (4594) to 6.29% from 7.29%.
- 2026-01-21
Phillip Securities Japan,Ltd. reduced holdings in BrightPath Biotherapeutics Co., Ltd. (4594) to 7.29% from 9.24%.
- 2026-01-20
Phillip Securities Japan,Ltd. reduced holdings in BrightPath Biotherapeutics Co., Ltd. (4594) to 9.24% from 18.94%.
- 2026-01-20
Holdings of Phillip Securities Japan,Ltd. in BrightPath Biotherapeutics Co., Ltd. (4594) moved below 10% (18.94% -> 9.24%).
- 2026-01-06
Phillip Securities Japan,Ltd. reduced holdings in BrightPath Biotherapeutics Co., Ltd. (4594) to 18.70% from 19.80%.
- 2026-01-06
Phillip Securities Japan,Ltd. filed a correction to a 5% report on BrightPath Biotherapeutics Co., Ltd. (4594).
- 2025-12-18
Phillip Securities Japan,Ltd filed a correction to a 5% report on BrightPath Biotherapeutics Co., Ltd. (4594).
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| フィリップ・キャピタル証券株式会社 | 2026-10-05 – 2026-10-05 | +34,500,000 | +19.90pt | — | — |
| フィリップ証券株式会社 | 2025-12-08 – 2026-02-17 | +100,845,200 | +80.52pt | — | — |
| Evo Fund | 2024-06-19 – 2025-07-04 | +3,969,000 | +4.89pt | ¥51.61 | ¥35–81 |
| Evolution Capital Management LLC | 2024-06-19 – 2025-07-04 | +3,969,000 | +4.89pt | ¥51.61 | ¥35–81 |
| マッコーリー バンク リミテッド | 2023-11-14 – 2024-07-08 | +15,733,500 | +20.37pt | ¥70.09 | ¥57–104 |
| Macquarie Bank Limited | 2022-01-14 – 2022-07-19 | +20,986,600 | +33.42pt | ¥49.99 | ¥35–107 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4594/trades.
5% filings
Large shareholding reports on 4594| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-10-07 | PhillipCapital Japan Ltd. | 19.90% | — | pure investment |
| 2026-02-19 | Phillip Securities Japan,Ltd. | 4.88% | −1.41pt | pure investment |
| 2026-01-29 | Phillip Securities Japan,Ltd. | 6.29% | −1.00pt | pure investment |
| 2026-01-21 | Phillip Securities Japan,Ltd. | 7.29% | −1.95pt | pure investment |
| 2026-01-20 | Phillip Securities Japan,Ltd. | 9.24% | −9.70pt | pure investment |
| 2026-01-06 | Phillip Securities Japan,Ltd. | 18.70% | −1.10pt | pure investment |
| 2026-01-06 | Phillip Securities Japan,Ltd. | 18.94% | −0.86pt | pure investment |
| 2025-12-18 | Phillip Securities Japan,Ltd | 19.80% | — | pure investment |
| 2025-12-18 | Phillip Securities Japan,Ltd | 19.57% | −0.23pt | pure investment |
| 2025-12-17 | Phillip Securities Japan,Ltd | 24.68% | — | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 2
Held by: The Chikuho Bank , Ltd. 8398, DAIICHI KOUTSU SANGYO Co.,Ltd. 9035
Purposes, all holdings and mutual flags via /v1/companies/4594/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| 楽天証券株式会社共有口 | 3,441,200 | 2.47% |
| 株式会社SBI証券 | 3,423,094 | 2.46% |
| 上田八木短資株式会社 | 2,800,000 | 2.01% |
| BNYM SA/NV FOR BNYM FOR BNY GCM CLIENT ACCOUNTS M LSCB RD | 1,857,304 | 1.33% |
| 日本証券金融株式会社 | 1,457,400 | 1.04% |
| 松井証券株式会社 | 1,449,900 | 1.04% |
| マネックス証券株式会社 | 1,143,971 | 0.82% |
| individual holder | 1,000,000 | 0.71% |
| 三菱UFJeスマート証券株式会社 | 796,000 | 0.57% |
| GMOクリック証券株式会社 | 664,000 | 0.47% |
Get this as JSON
GET /v1/companies/4594
GET /v1/companies/4594/financials
GET /v1/companies/4594/details
GET /v1/companies/4594/segments
GET /v1/companies/4594/voting
GET /v1/companies/4594/tender-offers
GET /v1/companies/4594/indicators
GET /v1/companies/4594/earnings-releases
GET /v1/events?ticker=4594
GET /v1/companies/4594/trades
GET /v1/companies/4594/cross-holdings
GET /v1/companies/4594/brief